Genetic description of a tick-borne encephalitis virus strain Sofjin with the longest history as a vaccine strain

Abstract

Vaccines based on the strain Sofjin of the Far-Eastern tick-borne encephalitis virus (TBEV) subtype have been used for TBE prophylaxis for over 50 years in Russia and neighboring countries. On the wide territory, where all known TBEV subtypes are circulating, the cultural, purified, concentrated, inactivated TBE vaccine Moscow has been shown to be safe and efficacious in a massive immunization. In the present work, we describe the genome of the vaccine strain Sofjin. We have shown that it differs from TBEV strains previously published with the name “Sofjin”. Moreover, we have shown the stability of the virus during the vaccine manufacturing process on the molecular level.